Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs80359584
rs80359584
A 0.700 GeneticVariation CLINVAR

dbSNP: rs113488022
rs113488022
0.010 GeneticVariation BEFREE We did not identify any tumours with the BRAF V600E mutation and transcriptome analysis revealed no significant differences between hypo- and hyper-methylated seminomas. 27886677

2016

dbSNP: rs121913377
rs121913377
0.010 GeneticVariation BEFREE We did not identify any tumours with the BRAF V600E mutation and transcriptome analysis revealed no significant differences between hypo- and hyper-methylated seminomas. 27886677

2016

dbSNP: rs3808350
rs3808350
0.010 GeneticVariation BEFREE Compared to control population, loss of homozygous ancestral genotype GG in two polymorphisms located in the promoter region of GPER (rs3808350 and rs3808351) was more frequent in seminomas but not in non-seminomas (respectively, OR = 1.960 (1.172-3.277) and 7.000 (2.747-17.840); p < 0.01). 24451139

2014

dbSNP: rs3808351
rs3808351
0.010 GeneticVariation BEFREE Compared to control population, loss of homozygous ancestral genotype GG in two polymorphisms located in the promoter region of GPER (rs3808350 and rs3808351) was more frequent in seminomas but not in non-seminomas (respectively, OR = 1.960 (1.172-3.277) and 7.000 (2.747-17.840); p < 0.01). 24451139

2014

dbSNP: rs34777958
rs34777958
0.010 GeneticVariation BEFREE In humans we identified heterozygous germline LRRC50 mutations in two different pedigrees with a family history of seminomas, resulting in a nonsense Arg488* change and a missense Thr590Met change, which show reduced expression of the wild-type allele in seminomas. 23599692

2013

dbSNP: rs7371084
rs7371084
0.010 GeneticVariation BEFREE Polymorphisms in ESR1 (rs9397080; OR=1.85, 95% CI: 1.18-2.91) and LHCGR (rs7371084; OR=2.37, 95% CI: 1.26-4.49) associated with risk of seminoma and metastasis, respectively. 22245602

2012

dbSNP: rs9397080
rs9397080
0.010 GeneticVariation BEFREE Polymorphisms in ESR1 (rs9397080; OR=1.85, 95% CI: 1.18-2.91) and LHCGR (rs7371084; OR=2.37, 95% CI: 1.26-4.49) associated with risk of seminoma and metastasis, respectively. 22245602

2012

dbSNP: rs1355972653
rs1355972653
0.010 GeneticVariation BEFREE Analyses of haplotypes for LTA-TNF SNPs (LTA -91C>A, LTA 252A>G, TNF -863C>A, TNF -857C>T, TNF -308G>A, and -238G>A) were similarly suggestive of an association with TGCT (P = 0.06) and nonseminoma (P = 0.04), but not seminoma (P = 0.21). 17220333

2007

dbSNP: rs745738344
rs745738344
TNF
0.010 GeneticVariation BEFREE Analyses of haplotypes for LTA-TNF SNPs (LTA -91C>A, LTA 252A>G, TNF -863C>A, TNF -857C>T, TNF -308G>A, and -238G>A) were similarly suggestive of an association with TGCT (P = 0.06) and nonseminoma (P = 0.04), but not seminoma (P = 0.21). 17220333

2007

dbSNP: rs1057519710
rs1057519710
KIT
0.010 GeneticVariation BEFREE A novel missense mutation (D816H) was found in the phosphotransferase domain in tumors of seminoma/dysgerminoma differentiation. 10362788

1999

dbSNP: rs121913506
rs121913506
KIT
0.010 GeneticVariation BEFREE A novel missense mutation (D816H) was found in the phosphotransferase domain in tumors of seminoma/dysgerminoma differentiation. 10362788

1999